This study is for women with high-risk cervical cancer. It's testing a new medicine called **Volrustomig** to see if it's safe and helpful. Women who join will be randomly put into two groups: one will get Volrustomig, and the other will get a placebo (a harmless pill that looks like the real medicine but isn't). This study is **double-blind**, meaning neither the doctors nor the participants know who gets the real medicine.

Key Points:

• The study is for women aged 15 and older with specific types of cervical cancer.
• Participants need to be healthy enough, with no signs of cancer spreading far from the cervix.
• The study involves regular check-ups and might last several months or longer.

To join, participants must agree to provide a small sample of their tumor for testing. They also must not have other serious health problems or have had certain treatments before. This study could help improve cancer treatment, but there may be risks, like side effects from the medicine. Always talk to your doctor before joining a study like this.